Published March, 2022
By Scott Gibbons
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Julian Millar
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Cooper Smith
Publisher: Elsevier (States Academic Press)
Rating:
Availability: Available

---

Published March, 2022
By Emilio Benfenati
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Divided into five sections, the volume covers the modeling of pharmaceuticals in the body, toxicity data for modeling purposes, in silico models for multiple endpoints, a number of platforms for evaluating pharmaceuticals, as well as an exploration of challenges, both scientific and sociological.

---

Published February, 2022
By Bir Bahadur, Chukwuebuka Egbuna, K. Saravanan, Horne Iona Averal, S. Kannan and S. Elavarasi
Publisher: Elsevier (Apple Academic Press Inc.)
Rating:
Availability: Available

Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases.

---

Published February, 2022
By Geraldo Wilson Fernandes, Yumi Oki and Milton Barbosa
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

This book has a broad scope and provides a comprehensive overview of the most up-to-date knowledge of the plant genus Baccharis. The book is organized into four major topics encompassing the evolution, ecology, chemistry, as well as environmental and medical applications of the genus.

---

Published February, 2022
By John D. Gatford, Nicole Phillips, Mathew Carey, Julie Martyn, Mathew C. Carey and Nicole M. Phillips
Publisher: Elsevier (Elsevier Health Sciences)
Rating:
Availability: Available

---

Published February, 2022
By Pietro Ghezzi, Harald H. H. W. Schmidt and Antonio Cuadrado
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants.

---

Published February, 2022
By Swati Gupta and Yashwant V. Pathak
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

The proposed book is envisioned for the nascent and entry-level researchers who are interested to work in the field of drug delivery and its applications specifically for macrophage targeting.

---

Published February, 2022
By Emilio Benfenati
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available

Divided into five sections, the volume covers the modeling of pharmaceuticals in the body, toxicity data for modeling purposes, in silico models for multiple endpoints, a number of platforms for evaluating pharmaceuticals, as well as an exploration of challenges, both scientific and sociological.

---